Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.8136
-0.0576 (-6.61%)
At close: May 15, 2026, 4:00 PM EDT
0.8100
-0.0036 (-0.44%)
Pre-market: May 18, 2026, 5:12 AM EDT
Skye Bioscience Employees
Skye Bioscience had 12 employees as of December 31, 2025. The number of employees decreased by 4 or -25.00% compared to the previous year.
Employees
12
Change (1Y)
-4
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$4,777,571
Market Cap
28.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | -4 | -25.00% |
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Kyntra Bio | 34 |
| Lisata Therapeutics | 21 |
| ABVC BioPharma | 19 |
| NeuroSense Therapeutics | 17 |
| Sensei Biotherapeutics | 15 |
| Barinthus Biotherapeutics | 14 |
| Traws Pharma | 7 |
SKYE News
- 5 days ago - UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 5 days ago - Skye Bioscience price target lowered to $6 from $13 at Piper Sandler - TheFly
- 6 days ago - Skye Bioscience reports Q1 EPS (32c), consensus (32c) - TheFly
- 6 days ago - Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 5 weeks ago - Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit - GlobeNewsWire
- 6 weeks ago - Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development - GlobeNewsWire
- 2 months ago - Skye Bioscience Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Skye Bioscience reports Q4 EPS (36c), consensus (31c) - TheFly